Swine interferon-induced transmembrane protein, sIFITM3, inhibits foot-and-mouth disease virus infection in vitro and in vivo

Antiviral Research

Volumn 109, Issue 1, 2014, Pages 22-29

  Xu, Jinfang ^a   Qian, Ping ^a   Wu, Qunfeng ^a   Liu, Shasha ^a   Fan, Wenchun ^a   Zhang, Keshan ^b   Wang, Rong ^a   Zhang, Huawei ^a   Chen, Huanchun ^a   Li, Xiangmin ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Antiviral activity; Foot and mouth disease virus; Swine IFITM3; Viral attachment

Indexed keywords

ANTIVIRUS AGENT; MEMBRANE PROTEIN; SWINE INTERFERON INDUCED TRANSMEMBRANE PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BHK CELL LINE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE EXPRESSION; HOST CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INNATE IMMUNITY; LIFE CYCLE STAGE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEQUENCE ALIGNMENT; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INHIBITION; VIRUS PATHOGENESIS; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMISTRY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; MOLECULAR GENETICS; PHYSIOLOGY; SWINE; VIROLOGY; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; SWINE; VIRUS ATTACHMENT; VIRUS REPLICATION;

EID: 84904156702     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.06.008     Document Type: Article

References (40)

1. S. Amini-Bavil-Olyaee, Y.J. Choi, J.H. Lee, M. Shi, I.C. Huang, M. Farzan, and J.U. Jung The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry Cell Host Microbe 13 2013 452 464
2. A.A. Anafu, C.H. Bowen, C.R. Chin, A.L. Brass, and G.H. Holm Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry J. Biol. Chem. 288 2013 17261 17271
3. S. Bhattacharyya, K.L. Warfield, G. Ruthel, S. Bavari, M.J. Aman, and T.J. Hope Ebola virus uses clathrin-mediated endocytosis as an entry pathway Virology 401 2010 18 28
4. A.L. Brass, I.C. Huang, Y. Benita, S.P. John, M.N. Krishnan, E.M. Feeley, B.J. Ryan, J.L. Weyer, L. van der Weyden, E. Fikrig, D.J. Adams, R.J. Xavier, M. Farzan, and S.J. Elledge The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus Cell 139 2009 1243 1254
5. R. Brem, K. Oraszlan-Szovik, S. Foser, B. Bohrmann, and U. Certa Inhibition of proliferation by 1-8U in interferon-alpha-responsive and non-responsive cell lines Cell. Mol. Life Sci. 60 2003 1235 1248 (Pubitemid 36791925)
6. B.M. Bronsvoort, S. Parida, I. Handel, S. McFarland, L. Fleming, P. Hamblin, and R. Kock Serological survey for foot-and-mouth disease virus in wildlife in eastern Africa and estimation of test parameters of a nonstructural protein enzyme-linked immunosorbent assay for buffalo Clin. Vaccine Immunol. 15 2008 1003 1011 (Pubitemid 351966999)
7. Y. Cao, Z. Lu, Y. Li, P. Sun, D. Li, P. Li, X. Bai, Y. Fu, H. Bao, C. Zhou, B. Xie, Y. Chen, and Z. Liu Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs Antiviral Res. 97 2013 145 153
8. T.E. Carpenter, J.M. O'Brien, A.D. Hagerman, and B.A. McCarl Epidemic and economic impacts of delayed detection of foot-and-mouth disease: a case study of a simulated outbreak in California J. Vet. Diagn. Invest. 23 2011 26 33
9. J. Chinsangaram, M.P. Moraes, M. Koster, and M.J. Grubman Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease J. Virol. 77 2003 1621 1625 (Pubitemid 36055585)
10. C.C. Dias, M.P. Moraes, M. Weiss, F. Diaz-San Segundo, E. Perez-Martin, A.M. Salazar, T. De los Santos, and M.J. Grubman Novel antiviral therapeutics to control foot-and-mouth disease J. Interferon Cytokine Res. 32 2012 462 473
11. E.M. Feeley, J.S. Sims, S.P. John, C.R. Chin, T. Pertel, L.M. Chen, G.D. Gaiha, B.J. Ryan, R.O. Donis, S.J. Elledge, and A.L. Brass IFITM3 inhibits influenza A virus infection by preventing cytosolic entry PLoS Pathog. 7 2011 e1002337
12. W.T. Golde, C.K. Nfon, and F.N. Toka Immune evasion during foot-and-mouth disease virus infection of swine Immunol. Rev. 225 2008 85 95
13. W.T. Golde, J.M. Pacheco, H. Duque, T. Doel, B. Penfold, G.S. Ferman, D.R. Gregg, and L.L. Rodriguez Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response Vaccine 23 2005 5775 5782 (Pubitemid 41668884)
14. M.J. Grubman, and B. Baxt Foot-and-mouth disease Clin. Microbiol. Rev. 17 2004 465 493 (Pubitemid 38534037)
15. I.C. Huang, C.C. Bailey, J.L. Weyer, S.R. Radoshitzky, M.M. Becker, J.J. Chiang, A.L. Brass, A.A. Ahmed, X. Chi, L. Dong, L.E. Longobardi, D. Boltz, J.H. Kuhn, S.J. Elledge, S. Bavari, M.R. Denison, H. Choe, and M. Farzan Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus PLoS Pathog. 7 2011 e1001258
16. R. Jia, Q. Pan, S. Ding, L. Rong, S.L. Liu, Y. Geng, W. Qiao, and C. Liang The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization J. Virol. 86 2012 13697 13707
17. D. Jiang, J.M. Weidner, M. Qing, X.B. Pan, H. Guo, C. Xu, X. Zhang, A. Birk, J. Chang, P.Y. Shi, T.M. Block, and J.T. Guo Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections J. Virol. 84 2010 8332 8341
18. S.P. John, C.R. Chin, J.M. Perreira, E.M. Feeley, A.M. Aker, G. Savidis, S.E. Smith, A.E. Elia, A.R. Everitt, M. Vora, T. Pertel, S.J. Elledge, P. Kellam, and A.L. Brass The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication J. Virol. 87 2013 7837 7852
19. H.L. Johns, S. Berryman, P. Monaghan, G.J. Belsham, and T. Jackson A dominant-negative mutant of rab5 inhibits infection of cells by foot-and-mouth disease virus: implications for virus entry J. Virol. 83 2009 6247 6256
20. S.M. Kim, J.H. Park, K.N. Lee, S.K. Kim, Y.J. Ko, H.S. Lee, and I.S. Cho Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-alpha and antiviral agents Antiviral Res. 96 2012 213 220
21. M. Lakadamyali, M.J. Rust, and X. Zhuang Endocytosis of influenza viruses Microbes Infect. 6 2004 929 936 (Pubitemid 39061215)
22. Y. Li, X. Huang, B. Xia, and C. Zheng Development and validation of a duplex quantitative real-time RT-PCR assay for simultaneous detection and quantitation of foot-and-mouth disease viral positive-stranded RNAs and negative-stranded RNAs J. Virol. Methods 161 2009 161 167
23. S.Y. Liu, D.J. Sanchez, R. Aliyari, S. Lu, and G. Cheng Systematic identification of type I and type II interferon-induced antiviral factors Proc. Natl. Acad. Sci. U.S.A. 109 2012 4239 4244
24. P. Molinari, S. Garcia-Nunez, M.J. Gravisaco, E. Carrillo, A. Berinstein, and O. Taboga Baculovirus treatment fully protects mice against a lethal challenge of FMDV Antiviral Res. 87 2010 276 279
25. H. Niwa, K. Yamamura, and J. Miyazaki Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 108 1991 193 199
26. W. Pengyan, R. Yan, G. Zhiru, and C. Chuangfu Inhibition of foot-and-mouth disease virus replication in vitro and in vivo by small interfering RNA Virol. J. 5 2008 86
27. M. Punta, P.C. Coggill, R.Y. Eberhardt, J. Mistry, J. Tate, C. Boursnell, N. Pang, K. Forslund, G. Ceric, J. Clements, A. Heger, L. Holm, E.L. Sonnhammer, S.R. Eddy, A. Bateman, and R.D. Finn The Pfam protein families database Nucleic Acids Res. 40 2012 D290 D301
28. L. Reed, and H. Muench A simple method of estimating fifty per cent endpoints Am. J. Hyg. 27 1938 493 497
29. L.L. Rodriguez, and C.G. Gay Development of vaccines toward the global control and eradication of foot-and-mouth disease Expert Rev. Vaccines 10 2011 377 387
30. A.J. Sadler, and B.R. Williams Interferon-inducible antiviral effectors Nat. Rev. Immunol. 8 2008 559 568 (Pubitemid 351913674)
31. F. Siegrist, M. Ebeling, and U. Certa The small interferon-induced transmembrane genes and proteins J. Interferon Cytokine Res. 31 2011 183 197
32. E. Siljamaki, N. Rintanen, M. Kirsi, P. Upla, W. Wang, M. Karjalainen, E. Ikonen, and V. Marjomaki Cholesterol dependence of collagen and echovirus 1 trafficking along the novel alpha2beta1 integrin internalization pathway PLoS One 8 2013 e55465
33. X. Sun, V.K. Yau, B.J. Briggs, and G.R. Whittaker Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells Virology 338 2005 53 60 (Pubitemid 40835926)
34. A.S. Tarakhovsky, and G. Kroemer Innate immunity Curr. Opin. Immunol. 24 2012 1 2
35. J.M. Weidner, D. Jiang, X.B. Pan, J. Chang, T.M. Block, and J.T. Guo Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms J. Virol. 84 2010 12646 12657
36. C. Wilkins, J. Woodward, D.T. Lau, A. Barnes, M. Joyce, N. McFarlane, J.A. McKeating, D.L. Tyrrell, and M. Gale Jr. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry Hepatology 57 2013 461 469
37. Q. Wu, L. Fang, X. Wu, B. Li, R. Luo, Z. Yu, M. Jin, H. Chen, and S. Xiao A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens Mol. Immunol. 46 2009 2210 2217
38. Q. Wu, S. Xiao, H. Fan, Y. Li, J. Xu, Z. Li, W. Lu, X. Su, W. Zou, M. Jin, H. Chen, and L. Fang Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine Antiviral Res. 2011
39. Q. Wu, F. Xu, L. Fang, J. Xu, B. Li, Y. Jiang, H. Chen, and S. Xiao Enhanced immunogenicity induced by an alphavirus replicon-based pseudotyped baculovirus vaccine against porcine reproductive and respiratory syndrome virus J. Virol. Methods 187 2013 251 258
40. P.C. Yang, R.M. Chu, W.B. Chung, and H.T. Sung Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan Vet. Rec. 145 1999 731 734 (Pubitemid 30009285)